4.7 Article

Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis

Journal

BRITISH JOURNAL OF CANCER
Volume 105, Issue 1, Pages 38-43

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2011.215

Keywords

gastric cancer; EBV; prevalence; pooled analysis

Categories

Funding

  1. National Cancer Institute, National Institutes of Health

Ask authors/readers for more resources

BACKGROUND: Meta-analyses of the published literature indicate that about 9% of gastric cancers contain Epstein-Barr virus (EBV), with consistent and significant differences by sex and anatomic subsite. This study aimed to identify additional determinants of EBV positivity and their joint effects. METHODS: From 15 international populations with consistent laboratory testing for EBV, we pooled individual-level data for 5081 gastric cancer cases including information on age, sex, subsite, histologic type, diagnostic stage, geographic region, and period of diagnosis. First, we combined population-specific EBV prevalence estimates using random effects meta-analysis. We then aggregated individual-level data to estimate odds ratios of EBV positivity in relation to all variables, accounting for within-population clustering. RESULTS: In unadjusted analyses, EBV positivity was significantly higher in males, young subjects, non-antral subsites, diffuse-type histology, and in studies from the Americas. Multivariable analyses confirmed significant associations with histology and region. Sex interacted with age (P = 0.003) and subsite (P = 0.002) such that male predominance decreased with age for both subsites. The positivity of EBV was not significantly associated with either stage or time period. CONCLUSION: Aggregating individual-level data provides additional information over meta-analyses. Distinguishing histologic and geographic features as well as interactions among age, sex, and subsite further support classification of EBV-associated gastric cancer as a distinct aetiologic entity. British Journal of Cancer (2011) 105, 38-43. doi: 10.1038/bjc.2011.215 www.bjcancer.com Published online 7 June 2011 (C) 2011 Cancer Research UK

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available